Position in CELU
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$59
+$58 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 39 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $1,028,190 across 22 Biotechnology names. CELU ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,091 | $680,282 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
191 | $94,875 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
161 | $86,448 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 5 | VTVT |
vTv Therapeutics Inc.
|
980 | $36,897 | |
| 6 | MRNA |
Moderna, Inc.
|
329 | $23,039 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
200 | $16,302 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
350 | $13,653 |
All Filings in CELU
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59 | 100 | Shares | Sole | 2026-07-29 | |
| 2023-06-30 | $1 | 1,000 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1 | 1,000 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1 | 1,000 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,310 | 1,000 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,400 | 1,000 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $8,710 | 1,000 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,120 | 1,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,080 | 1,000 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||